Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis

Journal of Molecular Medicine

Volumn 85, Issue 6, 2007, Pages 613-621

  Jacobsen, Marc ^a   Repsilber, Dirk ^b,d   Gutschmidt, Andrea ^a   Neher, Albert ^c   Feldmann, Knut ^c   Mollenkopf, Hans J ^a   Ziegler, Andreas ^b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^d UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Biomarkers; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ALPHA DEFENSIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BIOLOGICAL MARKER; CD64 ANTIGEN; FC RECEPTOR; FORMYLPEPTIDE RECEPTOR; GUANOSINE TRIPHOSPHATASE; LACTOFERRIN;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; INFLAMMATION; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TUBERCULOSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HEALTH; HUMANS; IMMUNITY, NATURAL; MALE; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IGG; TISSUE DONORS; TRANSCRIPTION, GENETIC; TUBERCULOSIS; UP-REGULATION;

EID: 34249948116     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0157-6     Document Type: Article

References (31)

1. Altman DG, Royston P (2000) What do we mean by validating a prognostic model? Stat Med 19:453-473
2. Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA (2001) N-formyl-methionyl-leucyl-phenylalanine inhibits both gamma interferon-and interleukin-10-induced expression of FcgammaRI on human monocytes. Clin Diagn Lab Immunol 8:402-408
3. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711-723
4. Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, Chen Y, Elkahloun A, Yu A, Bielekova B, Meltzer PS, Martin R, McFarland HF, Trent JM (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 12:2191-2199
5. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, Dohner H, Pollack JR (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605-1616
6. Chan YH (2005) Biostatistics 303. Discriminant analysis. Singap Med J 46:54-61, quiz 62
7. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, Wang CR (2001) Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med 193:1213-1220
8. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93-129
9. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Ziegler A, Kaufmann SH (2005) Ras-associated small GTPase 33A, a novel T cell factor, is downregulated in patients with tuberculosis. J Infect Dis 192:1211-1218
10. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B (2000) A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 26:495-499
11. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van Deutekom H, Speelman P, van der Poll T (1998) Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 178:1839-1842
12. Kalita A, Verma I, Khuller GK (2004) Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J Infect Dis 190:1476-1480
13. Kaufmann SH (2001) How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 1:20-30
14. Kaufmann SH, McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11:S33-S44
15. Le Y, Murphy PM, Wang JM (2002) Formyl-peptide receptors revisited. Trends Immunol 23:541-548
16. Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, Cho S, Krensky AM, Rollinghoff M, Nunes Sarno E, Burdick AE, Rea TH, Modlin RL (2001) T-cell release of granulysin contributes to host defense in leprosy. Nat Med 7:174-179
17. Perussia B, Dayton ET, Lazarus R, Fanning V, Trinchieri G (1983) Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med 158:1092-1113
18. Schaible UE, Collins HL, Priem F, Kaufmann SH (2002) Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 196:1507-1513
19. Sharma S, Verma I, Khuller GK (2000) Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. Eur Respir J 16:112-117
20. Shiloh MU, Nathan CF (2000) Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbiol 3:35-42
21. Snyderman R, Pike MC (1984) Chemoattractant receptors on phagocytic cells. Annu Rev Immunol 2:257-281
22. Stenger S, Modlin RL (2002) Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 14:452-457
23. te Velde AA, de Waal Malefijt R, Huijbens RJ, de Vries JE, Figdor CG (1992) IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 149:4048-4052
24. Ting LM, Kim AC, Cattamanchi A, Ernst JD (1999) Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 163:3898-3906
25. van de Winkel JG, Capel PJ (1993) Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14:215-221
26. Vanham G, Edmonds K, Qing L, Hom D, Toossi Z, Jones B, Daley CL, Huebner B, Kestens L, Gigase P, Ellner JJ (1996) Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol 103:30-34
27. Via LE, Deretic D, Ulmer RJ, Hibler NS, Huber LA, Deretic V (1997) Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Biol Chem 272:13326-13331
28. Ward PP, Uribe-Luna S, Conneely OM (2002) Lactoferrin and host defense. Biochem Cell Biol 80:95-102
29. Young PHWaSS (1993) Resampling-based multiple testing: examples and methods for p-value adjustment. Wiley
30. Zerial M, McBride H (2001) Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2:107-117
31. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf H-J, Kaufmann SHE, Ziegler A (2006) Deconfounding microarray analyses: independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. Methods Inf Med 45:557-563